Moreover, CFHR3,1Δ has been associated with a lower risk for the development of AMD and IgAN, whereas it increases the risk for systemic lupus erythematosus (SLE) and aHUS (because of anti-Factor H autoantibodies) [101,150,151,152]. Here, CFHR3 is linked to systemic lupus erythematosus.